Patexia Community

Innovation, Technology, and IP News

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Kyocera Senco Industrial Tools Inc. v. International Trade Commission, Appeal No. 2020-1046, -2050 (Fed. Cir. Jan. 21, 2022) The Federal Circuit’s only...

Feed tagged as "drug development":
ACTION:  Infringement of U.S. Patent 5,827,529 (referred to as “529 Patent) by Noven Therapeutics/Noven Pharmaceuticals, makers of products such as the... Read More »
Could it be possible to one day deliver miniscule factories to the human body to produce medicine? In an article in the American Chemical Society’s journal Nano... Read More »
As patents on major, money-making pharmaceuticals such as Lipitor, Plavix and Zyprexa run out and begin to face generic competition, drug companies have been... Read More »
Scientists have developed a process that would make the most effective anti-malarial treatment less costly. The new technique makes it easier to produce artemisinin... Read More »
Inflammation brought on by an influx of white blood cells and proteins helps the human body to heal when it’s faced with an acute infection or injury. But, at... Read More »
Two Michigan State University researchers have invented a protein purifier that will make  pharmaceutical production quicker and cheaper. Chemists Merlin... Read More »
International pharmaceutical giant Novartis is suing the United Kingdom's national health system (NHS) for using a cheaper, unlicensed drug instead of... Read More »
If you are one of the 48 percent of Americans that took a prescription drug in the past month, you probably read through a litany of potential side effects attributed ... Read More »
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life ... Read More »
Here's your weekly summary of the top medical news of the week! CellTex scandal breakdown: Stem cells, Rick Perry and the FDA There has been an explosion... Read More »
New technology could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality, personalized health care. Steven... Read More »
In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
Biological pharmaceuticals are therapeutic drugs made from human or animal materials rather than chemicals, often indicated for immune system-related deficiencies... Read More »
Transparency Life Sciences, LLC (TLS), a new drug development company, has launched a thoroughly innovative platform for clinical studies, with an objective of... Read More »